Insider filing · DXCM
Jereme M Sylvain
EVP, Chief Financal Officer
profile →
DexCom, Inc.
DXCM · Healthcare · 49 filings in 24 months
ticker →
Jereme M Sylvain sold $845K of DexCom (DXCM)
Executed Mar 12 2025, disclosed Mar 14 2025, 2 days later.
Value, as filed
$845K
12,001 sh × $70.38
Executed
Mar 12 2025
the trade date, as filed
Disclosed
Mar 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JSJereme M Sylvain (EVP, Chief Financal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in DexCom, Inc. (DXCM). The largest single filing was $303K of DXCM (3,638 sh × $83.27, as filed), executed Sep 10.
The name
DXCMHealthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jereme M Sylvain in DXCM
DXCMSALE
DexCom, Inc.
$303K3,638 sh × $83.27
Exec Sep 10
Filed Sep 14 · 4:02 PM ET DXCMSALE DexCom, Inc. $358K
4,824 sh × $74.17
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. $433K
5,873 sh across 2 lots
Exec Mar 10 2025
Filed Mar 11 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. $182K
2,090 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. $264K
3,500 sh × $75.51
Exec Nov 15 2024
Filed Nov 18 2024 · 5:30 PM ET